Related Experiment Videos
Nutritional strategy in the management of heart failure in adults
I Bourdel-Marchasson1, J P Emeriau
1Centre de Gériatrie Henri Choussat, Hôpital Xavier Arnozan, Centre Hospitalo-Universitaire de Bordeaux, Bordeaux, France. isabelle.bourdel-marchasson@chu-bordeaux.fr
Insights
Congestive heart failure (CHF) patients often experience malnutrition, known as cardiac cachexia, which increases mortality. Nutritional support, especially perioperatively, shows promise, but long-term studies are needed for management recommendations.
Area of Science:
- Cardiology
- Nutrition Science
- Metabolic Disorders
Background:
- Congestive heart failure (CHF) incidence is rising globally, leading to reduced quality of life and increased mortality.
- Malnutrition, termed cardiac cachexia, is prevalent in CHF patients and independently linked to higher mortality rates.
- Cardiac cachexia is characterized by significant lean body mass loss, clinically defined by specific body weight reduction over time.
Purpose of the Study:
- To explore the mechanisms of malnutrition in CHF patients.
- To review the impact of malnutrition on functional capacity and mortality in CHF.
- To evaluate potential therapeutic strategies, including nutritional interventions, for cardiac cachexia.
Main Methods:
- Literature review of studies on CHF, malnutrition, and cardiac cachexia.
- Analysis of neurohormonal alterations and cytokine release in CHF-related malnutrition.
- Examination of the effects of malnutrition on skeletal muscle function and energy expenditure.
Main Results:
- Energy requirements in CHF are not significantly altered, but anorexia can occur during decompensation.
- Malnutrition impairs muscle function through decreased mass, strength, and altered fiber types.
- Perioperative nutritional support in surgical CHF patients reduces mortality, suggesting potential benefits of nutritional interventions.
Conclusions:
- Long-term nutritional supplementation trials are essential to establish evidence-based recommendations for managing malnutrition in CHF patients.
- Understanding the neurohormonal and cytokine pathways is crucial for developing targeted therapies.
- Further research is needed to confirm the efficacy of anabolic and anticytokine therapies for cardiac cachexia.
Abstract:
The incidence of congestive heart failure (CHF) is increasing in Westernized countries, and patients with CHF experience poor quality of life (functional impairment, high hospitalization rate and high mortality). Malnutrition occurring during the course of CHF is referred to as cardiac cachexia and is associated with higher mortality independent of the severity of CHF. Cardiac cachexia involving a loss of more than 10% of lean body mass can clinically be defined as a bodyweight loss of 7.5% of previous dry bodyweight in a period longer than 6 months. The energy requirements of patients with CHF, whether cachectic or not, are not noticeably modified since the increase in resting energy expenditure is compensated by a decrease in physical activity energy expenditure. Malnutrition in CHF has been ascribed to neurohormonal alterations, i.e. anabolic/catabolic imbalance and increased cytokine release. Anorexia may occur, particularly during acute decompensation of CHF. Function is impaired in CHF, because of exertional dyspnea and changes in skeletal muscle. Decreased exercise endurance seems to be related to decreased mitochondrial oxidative capacities and atrophy of type 1 fibers, which are attributed to alteration in muscle perfusion and are partially reversible by training. Malnutrition could also impair muscle function, because of decreased muscle mass and strength associated with decreased glycolytic capacities and atrophy of type 2a and 2b fibres. With respect to the putative mechanisms of cardiac cachexia, anabolic therapy (hormones or nutrients) and anticytokine therapy have been proposed, but trials are scarce and often inconclusive. In surgical patients with CHF, perioperative (pre- and postoperative) nutritional support has been shown to be effective in reducing the mortality rate. Long term nutritional supplementation trials in patients with CHF and cachexia are thus required to establish recommendations for the nutritional management of patients with CHF.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Mitral Regurgitation IV: Nursing Management
Cardiomyopathy VI: Nursing Management
Heart Failure IV: Classification and Diagnostic Evaluation